T. BOGRI

421 total citations
22 papers, 284 citations indexed

About

T. BOGRI is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, T. BOGRI has authored 22 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Organic Chemistry and 8 papers in Pharmacology. Recurrent topics in T. BOGRI's work include Inflammatory mediators and NSAID effects (6 papers), Synthetic Organic Chemistry Methods (3 papers) and Biological Activity of Diterpenoids and Biflavonoids (3 papers). T. BOGRI is often cited by papers focused on Inflammatory mediators and NSAID effects (6 papers), Synthetic Organic Chemistry Methods (3 papers) and Biological Activity of Diterpenoids and Biflavonoids (3 papers). T. BOGRI collaborates with scholars based in Canada, Greece and United States. T. BOGRI's co-authors include Jehan F. Bagli, K. Wiesner, Yves Bousquet, Paul C. Anderson, Ingrid Guse, Louis Grenier, Romano Deghenghi, Abraham, Pierre L. Beaulieu and Pierre Lavallée and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Cellular and Molecular Life Sciences.

In The Last Decade

T. BOGRI

21 papers receiving 243 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. BOGRI Canada 11 170 106 66 26 25 22 284
Yvon G. Perron United Kingdom 12 201 1.2× 151 1.4× 68 1.0× 22 0.8× 13 0.5× 23 376
Clint D. W. Brooks United States 9 139 0.8× 100 0.9× 86 1.3× 25 1.0× 27 1.1× 17 298
Robert F. R. Church United States 9 200 1.2× 162 1.5× 38 0.6× 21 0.8× 18 0.7× 17 347
W. V. Ruyle United States 10 129 0.8× 125 1.2× 44 0.7× 14 0.5× 7 0.3× 15 275
John S. Ng United States 11 362 2.1× 184 1.7× 40 0.6× 16 0.6× 24 1.0× 18 466
Ettore Lazzari Italy 9 179 1.1× 182 1.7× 36 0.5× 11 0.4× 15 0.6× 13 329
A. R. Hanze United States 10 97 0.6× 154 1.5× 18 0.3× 18 0.7× 16 0.6× 16 259
Hollis S. Kezar United States 10 241 1.4× 224 2.1× 45 0.7× 19 0.7× 24 1.0× 15 447
Katsuya Awano Japan 10 161 0.9× 173 1.6× 42 0.6× 12 0.5× 47 1.9× 17 332
Timothy C. Barden United States 9 230 1.4× 75 0.7× 23 0.3× 23 0.9× 14 0.6× 18 304

Countries citing papers authored by T. BOGRI

Since Specialization
Citations

This map shows the geographic impact of T. BOGRI's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. BOGRI with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. BOGRI more than expected).

Fields of papers citing papers by T. BOGRI

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. BOGRI. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. BOGRI. The network helps show where T. BOGRI may publish in the future.

Co-authorship network of co-authors of T. BOGRI

This figure shows the co-authorship network connecting the top 25 collaborators of T. BOGRI. A scholar is included among the top collaborators of T. BOGRI based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. BOGRI. T. BOGRI is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Papakyriakopoulou, Paraskevi, et al.. (2025). Cyclodextrin-Based Quercetin Powders for Potential Nose-to-Brain Transport: Formulation and In Vitro Assessment. Molecules. 30(13). 2878–2878.
2.
Beaulieu, Pierre L., Dominik Wernic, Abraham, et al.. (1997). Potent HIV Protease Inhibitors Containing a Novel (Hydroxyethyl)amide Isostere. Journal of Medicinal Chemistry. 40(14). 2164–2176. 23 indexed citations
3.
Bousquet, Yves, Paul C. Anderson, T. BOGRI, et al.. (1997). Preparation of enantiopure 4-oxygenated pipecolic acid derivatives. Tetrahedron. 53(46). 15671–15680. 17 indexed citations
4.
Gillard, James, Abraham, Paul C. Anderson, et al.. (1996). Preparation of (2S,4R)-4-Hydroxypipecolic Acid and Derivatives. The Journal of Organic Chemistry. 61(6). 2226–2231. 53 indexed citations
5.
Bagli, Jehan F., T. BOGRI, B. Palameta, et al.. (1988). Chemistry and positive inotropic effect of pelrinone and related derivatives. A novel class of 2-methylpyrimidones as inotropic agents. Journal of Medicinal Chemistry. 31(4). 814–823. 14 indexed citations
6.
Bagli, Jehan F., et al.. (1986). Troponoids. 7. Chemistry and dopamine agaonist activity of ciladopa and related aralkyltroponylpiperazines. Journal of Medicinal Chemistry. 29(2). 186–193. 3 indexed citations
7.
Bagli, Jehan F., T. BOGRI, & Katherine Voith. (1984). Troponoids. 6. Troponylpiperazines: a new class of dopamine agonists. Journal of Medicinal Chemistry. 27(7). 875–881. 3 indexed citations
8.
Bagli, Jehan F. & T. BOGRI. (1975). Prostaglandin VIII — Synthesis of some 9-oxoprostynoic acids. Prostaglandins. 10(3). 503–506. 1 indexed citations
9.
Bagli, Jehan F. & T. BOGRI. (1975). Prostaglandin VIII — Synthesis of some 9-oxoprostynoic acids. Prostaglandins. 10(4). 503–506. 1 indexed citations
10.
Bagli, Jehan F., T. BOGRI, & Suren N. Sehgal. (1973). ChemInform Abstract: PROSTAGLANDIN PART 7, 15‐METHYL‐15‐HYDROXY‐9‐OXOPROSTANOIC ACID, A POTENT ORALLY ACTIVE ANTISECRETORY AGENT. Chemischer Informationsdienst. 4(49). 1 indexed citations
11.
Bagli, Jehan F., T. BOGRI, & Suren N. Sehgal. (1973). Prostaglandin VII - 15-methyl-15-hydroxy-9-oxoprostanoic acid - a potent orally active antisecretory agent. Tetrahedron Letters. 14(35). 3329–3332. 6 indexed citations
12.
Bagli, Jehan F. & T. BOGRI. (1972). Prostaglandins. IV. Total syntheses of dl-11-deoxy PGE1 and 13,14-dihydro derivatives of 11-deoxy PGE1, PGF1.alpha. and PGF1.beta.. The Journal of Organic Chemistry. 37(13). 2132–2138. 23 indexed citations
13.
14.
Bagli, Jehan F. & T. BOGRI. (1969). Prostaglandins III - ±11-deoxy-13,14-dihydroprostaglandin F1α and F1β - a novel synthesis of prostanoic acids. Tetrahedron Letters. 10(21). 1639–1644. 18 indexed citations
15.
Götz, Marion G., et al.. (1968). The structure of tuberostemonine. Tetrahedron. 24(6). 2631–2643. 22 indexed citations
16.
Bagli, Jehan F. & T. BOGRI. (1967). Prostaglandins II - an improved synthesis and structural proof of (±)-11-deoxyprostaglandin F1β. Tetrahedron Letters. 8(1). 5–10. 23 indexed citations
17.
Bagli, Jehan F., T. BOGRI, Romano Deghenghi, & K. Wiesner. (1966). Prostaglandins I - total synthesis of 9β,15X-dihydroxyprost-13-enoic acid. Tetrahedron Letters. 7(5). 465–470. 30 indexed citations
18.
BOGRI, T., et al.. (1965). The complete structure of ryanodine. Cellular and Molecular Life Sciences. 21(8). 425–430. 4 indexed citations
19.
Valenta, Z., et al.. (1962). On the structure of ryanodol. Cellular and Molecular Life Sciences. 18(3). 111–113. 6 indexed citations
20.
Götz, Marion G., et al.. (1961). The structure of tuberostemonine. Tetrahedron Letters. 2(20). 707–715. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yvon G. Perron Breakdown of academic impact, for papers by Clint D. W. Brooks Breakdown of academic impact, for papers by Robert F. R. Church Breakdown of academic impact, for papers by W. V. Ruyle Breakdown of academic impact, for papers by John S. Ng Breakdown of academic impact, for papers by Ettore Lazzari Breakdown of academic impact, for papers by A. R. Hanze Breakdown of academic impact, for papers by Hollis S. Kezar Breakdown of academic impact, for papers by Katsuya Awano Breakdown of academic impact, for papers by Timothy C. Barden
Rankless by CCL
2026